Brian B. Berger, M.D.

Education:

Certifications  Fellow, American Board of Ophthalmology
Fellowship Fellowship in Diseases of the Retina and Vitreous, Medical College of Wisconsin, Milwaukee, Wisconsin, 1979 - 1980
Residency Ophthalmology Residency, University of Illinois, Chicago, Illinois, 1976 - 1979
Internship Rotating Internship, Maricopa County General Hospital, Phoenix, Arizona, 1975 - 1976
Graduate University of Chicago, Chicago, Ill. M.D., 1971 - 1975
Undergraduate University of Illinois, Urbana, Ill. Major: B.S. in Biology with high honors and high distinction, 1967 - 1971
Licenses Illinois 1976, 036-052947
Wisconsin 1979, 22289
Texas 1981, G0354

Organizations

Campos Society 1984-present

American Medical Association, 1974 - present

Texas Ophthalmological Assn., 1981 - present

Fellow, American Academy of Ophthalmology, 1981 - present

American Uveitis Society, 1978 - present

American Society of Retinal Surgeons, 1986 - present

Texas Affiliate of the American Diabetes Assn., 1984 - present

President, Capital Chapter, American Diabetes Association,1987

President, Austin Ophthalmology Society, 1988-90

Austin Ophthalmology Society, 1984 - present

Association for Research in Vision and Ophthalmology, 1980 - 1984

Texas Medical Association, 1980 - present

Illinois Eye and Ear Infirmary Alumni Association, 1980 - present

Retina Society member, 1998 - present

Prevent Blindness Texas, Director, Austin, Texas, 2001 - 2003

Honors:

Vitreous Society Honor Award, September 1997

American Academy of Ophthalmology Achievement Award, 1999

 

Work History:

Brian B. Berger, M.D., P.A., Austin, TX 1995 - present
Retina Research Center, PLLC, Austin, Texas  1995 - present
Retina Consultants of Texas, P.A., Austin, TX 1993 - 1995
Retina Clinic of Austin, Austin, TX 1984 - 1993
Scott & White Clinic, Temple, TX 1980 - 1984

Books Published and Authored:

Berger BB: Anterior Vitrectomy. Chapter 22, page 217, " Vitreoretinal Surgical
Techniques," Gholam A. Peyman, Stephen A. Meffert, Famin Chou, Mandi D. Conway. Taylor and Francis, 2007.

Berger BB: Anterior Vitrectomy. Atlas of Vitreoretinal Surgery, GA Peyman, S Meffert,
F Chou and M Conway. Martin Dunitz, Ltd., 2000.

Berger BB: Acute Iridocyclitis, Chronic Iridocyclitis, Intermediate Uveitis, Retinitis,
Choroiditis, Panuveitis, Principles of Uveitis Treatment. Decision Making in
Ophthalmology, WA van Heuven, JT Zwann. C.V. Mosby, 1992.

Berger BB: The lens, cataract and its management, Chapter 7, Principles and Practice of
Ophthalmology. Edited by GA Peyman, DR Sanders and MF Goldberg. W.B.
Saunders Co, Philadelphia, 1980.

Refereed Publications:

Matthew D. Davis, Susan B. Bressler. Lloyd Paul Aiello, Neil M. Bressler, David J.
Browning, Christina J. Flaxel, Donald S. Fong, William J. Foster, Adam R. Glassman, Mary Elizabeth R. Hartnett, Craig Kollman, Helen K. Li, Haijing Qin, Ingrid U. Scott and the Diabetic Retinopathy Clinical Research Network Study Group: Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in eyes with Diabetic Macular Edema. Protocol A - Laser Photocoagulation for Diabetic Macular Edema. Invest Ophthalmol Vis Sci 2008;49:1745-52

Neil M. Bressler, Allison R. Edwards , Andrew N. Antoszyk, Roy W. Beck, David J.
Browning, Antonio P. Ciardella, Ronald P. Danis, Michael J. Elman, Scott M. Friedman, Adam R. Glassman, Jeffrey G. Gross, Helen K. Li, Timothy J. Murtha, Thomas W. Stone, Jennifer K. Sun on behalf of the Diabetic Retinopathy Clinical Research Network: Retinal thickness on stratusŞ optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Protocol G - Subclinical Diabetic Macular Edema Study.Am J Ophthalmol 2008'145:894-901

Chan CK, Berger BB, Joondeph BC, Diagnostic and Therapeutic Challenges. Retina: The The Journal of Retinal and Vitreous Diseases; 27(1): 101-105.

Banker AS, Freeman WR, Agon SP, Lai MY and the Vitrectomy for Macular Hole Study Group: A Multicentered clinical trial of serum as adjuvant therapy for surgical treatment of macular holes. In press: Am J Ophthalmol.

Freeman WR, Kim JW, Azen SP, Wael EH, Mishell MS, Bailey, IL, The Vitrectomy for Macular Hole Study Group: Vitrectomy for the treatment of full-thickness stage III or IV macular holes: Results of a multicentered randomized clinical trial. Archives of Ophthalmology 1997; 115: 11-21.

Banker AS, Freeman WR, Kim JW, Azen SP, Munguia D, The Vitrectomy for Macular Hole Study Group: Vision threatening complications of surgery for full thickness macular holes. Ophthalmology 1997; 115: 1214-1215.

Moorthy RS, Weinberg DV, Teich SA, Berger BB, Minturn JT, Kumar S, Rao NA, Fowell SM, Loose LA, Jampol LM: Medical and surgical management of progressive outer retinal necrosis (PORN) in acquired immunodeficiency syndrome. Br. J. Ophthalmol. 81: 189-194, 1997.

Kim JW, Freeman WR, Wael EH, Klein DJ, Azen SP, Bailey, IL, The Vitrectomy for Macular Hole Study Group: Prospective randomized trial of vitrectomy versus for observation for stage II macular holes. Am J Ophthalmol 121: 605614, 1996.

Kim JW, Freeman WR, Wael EH, Macquire, Arevalo F, Azen SP, Bailey, IL, The Vitrectomy for Macular Hole Study Group: Baseline characteristic, natural history and risk factors to progression in eyes with stage II macular holes. Am J Ophthalmol 102: 1818-29, 1995.

De Bustros S, Freeman WR and the Vitrectomy for Prevention of Macular Hole Study Group: Vitrectomy for prevention of macular hole trial: results of a randomized multicenter trial. Ophthalmology 101: 1055-1060, 1994.

Berger BB, Egwuagu CE, Freeman WR, Wiley CA: Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome. Arch Ophthalmol 111: 373-376, 1993.

Berger BB, Heads Up: Legal Case May Affect Valuing of Medical Practices, Letter to the Editor, Texas Medicine 88(10): 9, 1992.

Sneed SR, Blodi CF, Berger BB, Speights JW, Folk JC, Weingeist TA: Pneumocystis carinii choroiditis in patients receiving inhaled pentamidine. New England Journal of Medicine 322: 936-937, 1990.

Holland GN, Engstrom RE, Glasgow BJ, Berger BB, Daniels SA, Sidikaro Y, Harmon JA, Fischer DH, Boyer DS, Rao NA, Eagle RC, Kreiger AE, and Foos RY: Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 106: 653-667, 1988.

Berger BB: Eye color affects cyclocryotherapy-induced inflammation. Ophthalmic Surgery 16: 206, 1985.

Berger BB: Letter to editor re: Successful treatment of postoperative candida endophthalmitis in an eye with an intraocular lens implant. Am J Ophthalmol 98: 648-649, 1984.

Berger BB: Foveal photocoagulation from laser iridotomy. Ophthalmol 91: 1029-1033, 1984.

Berger BB: Branch vein occlusion: Traction macular detachment. Ann Ophthalmol 16: 623-624, 1984.

Berger BB: Repeater unit for laser surgery. Am J Ophthalmol 97: 104, 1984.

Berger BB; The laser in ophthalmology. Texas Medicine, October 1982.

Dieckert JP and Berger BB: Prostatic carcinoma metastatic to the choroid. Brit J Ophthalmol 66: 234-239, April 1982.

Berger BB: Endophthalmitis complicating neonatal Group B streptococcal septicemia. Am J Ophthalmol 92: 681-684, 1981.

Berger BB and Reeser F: Retinal pigment epithelial detachments in posterior scleritis. Am J Ophthalmol 90: 604, 1980.

Berger BB, Tessler H and Kottow M: Anterior segment ischemia in FuchsŐ Heterochromic cyclitis. Arch Ophthalmol 98: 499, 1980.

Berger BB, Zweig KO and Peyman GA: Vitreous loss managed by anterior vitrectomy: Long-term follow-up of 59 cases. Arch Ophthalmol 98: 1245, 1980.

Berger BB, Weinberg RS, Tessler HH, Vygantus CM, and Wyhinny G: Bilateral cytomegalovirus panuveitis following high dose steroid therapy. Am J Ophthalmol 88: 1020, 1979.

Berger BB and Frankel M: Complete third nerve paralysis and decreasing vision secondary to subdural hematoma. Ann Ophthalmol 11: 1817, 1979.

Berger BB, Peyman GA, Juarez C, Mason G and Raichand M: Massive retinal gliosis clinically simulating a choroidal melanoma. Canad J Ophthal 14: 285, 1979.

Berger BB, Wainer BH, Bonese KF, Schuster CW, Fitch FW, and Rothberg RM: The interaction of morphine with sera from monkeys physically dependent on morphine. Clin Immunol Immunopath 4: 317, 1975.

Non-Refereed Publications:

Berger BB: Anterior vitrectomy aids cataract surgery complications. Ophthalmology Times 26: 8-13, 2001.

Berger BB: How to manage iridocyclitis. Review of Ophthalmology, August 1995.

Berger BB, Jeffcoat W and McCollum T: Irrigating contact lens. Ocutome/Fragmatome Newsletter 7 (3): 1, 1982.

Scientific Posters:

Photodynamic Therapy for Classic Choroidal Neovascularization Secondary to Juxtafoveal Telangiectasis. Vitreous Society 18th Annual Meeting, Cancun, Mexico, January 2000.

Retinal manifestations of Bartonella Henselae. American Academy of Ophthalmology Annual Meeting, October 1997, San Francisco, California.

Retinal manifestations of Bartonella Henselae. XX Meeting of the Club Jules Gonin, Bern, Switzerland, September 1997.

Stem cell assay of choroidal melanoma. American Academy of Ophthalmology Annual Meeting, Chicago, October 1983.

Academic Appointments:

Clinical Professor of Ophthalmology, University of Texas Health Science Center at San Antonio, 1998 - present.

Clinical Asst. Professor of Ophthalmology, University of Texas Health Science Center at San Antonio, 1984 - 1997.

Assistant Professor of Surgery, Texas A&M University, College of Medicine, 1981 -1983.

Instructor, Department of Ophthalmology, Medical College of Wisconsin, 1979 - 1980.

Instructor in Ophthalmology, University of Illinois, 1978 - 1979.

Teaching:

Chief, Uveitis Consultation Service; core curriculum in uveitis. University of Texas Health Science Center at San Antonio, 1984 - present.

Anterior Vitrectomy Techniques for the Comprehensive Ophthalmologist, Course Director, American Academy of Opthalmology, Orlando, Florida, October 1999.

Anterior Vitrectomy Techniques for the Comprehensive Ophthalmologist, Course Director, American Academy of Opthalmology, New Orleans, Louisiana, November 1998.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, San Francisco, California, October 1997.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, Chicago, Illinois, October 1996.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, Atlanta, Georgia, October 1995.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, San Francisco, California, November 1994.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, Chicago, Illinois, November 1993.

An Algorithmic Approach to Posterior Uveitis, Course Director, American Academy of Ophthalmology, Dallas, Texas, November 1992.

The Management of Posterior Uveitis for the Practicing Ophthalmologist, Course Director, American Academy of Ophthalmology, Anaheim, California, October 1991.

The Management of Posterior Uveitis for the Practicing Ophthalmologist, Course Director, American Academy of Ophthalmology, Atlanta, Georgia, October 1990.

The Management of Posterior Uveitis for the Practicing Ophthalmologist, Course Director, American Academy of Ophthalmology, New Orleans, Louisiana, October 1989.

Vitrectomy Workshop, Course Director, Scott and White Clinic and Texas A&M University College of Medicine, Austin, Texas, October 1983.

Macular Degeneration Update, Course Director, Scott and White Clinic and Texas A&M University College of Medicine, Temple, Texas, September 1982.

Vitrectomy course, instructor, Medical College of Wisconsin, Milwaukee, Wisconsin, May 1980.

Clinical Research:

Principal Investigator: Intravitreal bevasiranib sodium, administered every 8 or 12 weeks as maintenance therapy following three injections of Lucentis compared with Lucentis monotherapy every 4 weeks in Exudative Age-Related Macular Degeneration (Opko Cobalt)

Principal Investigator: Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration (Regeneron 0605)

Principal Investigator: ATG003 (mecamylamine HCL) 1.0% and 0.3% ophthalmic solutions to placebo in patients with neovascular (wet) age-related macular degeneration (Comentis ATG201)

Principal Investigator: Ranibizumab injections in subjects with clinically significant macular edema with center involvement secondary to diabetes mellitus (Genentech RISE)

Principal Investigator: Microplasmin Intravitreal Injection For Non-Surgical Treatment Of Focal Vitreomacular Adhesion (Thrombogenics TG-MV-007)

Principal Investigator: ATG003 in Patients with Neovascular Age-Related Macular Degeneration (NV-AMD) Receiving Frequent Maintenance Intravitreal Anti-VEGFAntibody Therapy (Comentis ATG203)

Principal Investigator: Ranibizumab injections in subjects with macular edema secondary to Branch Retinal Vein Occlusion (Genentech BRAVO)

Principal Investigator: Ranibizumab injections in subjects with macular edema secondary to Central Retinal Vein Occlusion (Genentech CRUISE)

Principal Investigator: Extension Study to Evaluate the Saftey and Tolerability of Ranibizumab in Subjects with Macular Edema secondary to Branch and Central Retinal Vein Occlusion who have completed BRAVO or CRUISE (Horizon)

Principal Investigator: Pazopanib eye drops, administered for 28 days to adult subjects with neovascular age-related macular degeneration (GSK MD7108240)

Principal Investigator: Macular Edema Secondary to Diabetic Retinopathy (Macusight DR002)

Principal Investigator: Lucentis¨ plus Sirolimus versus Lucentis¨ plus Placebo in Patients with Sub-Foveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (Macusight AMD003)

Principal Investigator: Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration (Regeneron 0702)

Principal Investigator: Repeated Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema (Regeneron 0706)

Principal Investigator: A study to assess the efficacy of AEB071 in the treatment of uveitis (Novartis CAEB071A2211)

Principal Investigator: Dose Ranging Study of CP-690,550 in Subjects with Dry Eye Disease (Pfizer A3921034)

Principal Investigator: Case-Crossover Study of PDE5 Inhibitor Exposure as a Potential "Trigger Factor" for Acute NAION (Pfizer NAION)

Principal Investigator: Intravitreal Administration of Two VEGF Trap Formulations in Subjects with Neovascular Age Related Macular Degeneration, 2007. (Regeneron 0603)

Principal Investigator: CNV Secondary AMD Treated with Beta Radiation Epiretinal Therapy, 2007. (Neovista Cabernet)

Principal Investigator: LX211 as Therapy in Subjects with Active Sight Threatening, Non-infectious Intermediate-, Anterior- and Intermediate-, Posterior-, or Pan-Uveitis, 2007. (Lux 01)

Principal Investigator: LX211 as Therapy in Subjects with Clinically Quiescent Sight Threatening, Non-infectious, Intermediate-, Anterior- and Intermediate-, Posterior-, and Pan-Uveitis, 2007. (Lux 02)

Principal Investigator: LX211 as Therapy in Subjects with Active Sight Threatening, Non-infectious Anterior Uveitis, 2007. (Lux 03)

Principal Investigator: Randomized 700 µg and 300 µg DEX PS DDS Compared with a Sham for the Treatment of Non-infectious Ocular Inflammation of the Posterior Segment in Patients with Intermediate or Posterior Uveitis, 2007. (Allergan Uveitis 014)

Principal Investigator: Visudyne Photodynamic Therapy Administered in Conjunction with Ranibizumab (Lucentis) versus Lucentis Monotherapy in Patients with Subfoveal Chorodial Neovascularization Secondary to Age-related Macular Degeneration, 2007. (Denali, Novartis)

Principal Investigator: Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema, 2007. (DRCR-I).

Principal Investigator: Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy, 2007. (DRCR-J)

Principal Investigator: Course of Response to Focal Photocoagulation for Diabetic Macular Edema, 2007. (DRCR-K)

Principal Investigator: Randomized ASI-001A 0.5 µg/day and ASI-001B 0.2 µg/day Fluocinolone Acetonide Intravitreal Inserts Versus a Sham Injection for Subjects with Diabetic Macular Edema, 2006. (Alimera FAME)

Principal Investigator: Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema using Bevacizumab (Avastin), 2006. (DRCR-H)

Principal Investigator: Evaluation of Vitrectomy for Diabetic Macular Edema, 2006. (DRCR-D)

Principal Investigator: Intravitreal Triamcinolone Acetonide versus Laser Photocoagulation for Subjects with Diabetic Macular Edema, 2006. (DRCR-B)

Principal Investigator: Laser Photocoagulation for Subjects with Diabetic Macular Edema, 2006. (DRCR-A)

Principal Investigator: Longitudinal Database to Capture Patient Demographics and Treatment Outcomes in Patients with CNV Secondary to AMD, 2005 (InSight)

Principal Investigator: Visudyne Plus Two Different Dose Regimens of Intravitreal Triamcinolone Acetonide versus Visudyne plus Macugen in Subjects with CNV Secondary to AMD, 2005 (Veritas, Novartis)

Principal Investigator: Extension Study to Evaluate the Saftey and Tolerability of Ranibizumab in Subjects with CNV Secondary to AMD Who Have Completed Another Genentech Trial, 2005 (Horizon)

Principal Investigator: Safety and Tolerability of Ranibizumab in Na•ve and Previously Treated Subjects with CNV Secondary to AMD, 2005 (Sailor)

Principal Investigator: Pegaptanib Sodium Intravitreal Injection in patients with Macular Edema secondary to Central Retinal Vein Occulsions, 2005 (Eyetech).

Principal Investigator: Squalamine Lactate Injection administered for treatment of Subfoveal Choroidal Neovascularization secondary to Age-Related Macular Degeneration, 2005 (Genaera).

Principal Investigator: Cand5 Intravitreal Injection administered for treatment of Subfoveal Choroidal Neovascularization secondary to Wet Age-Related Macular Degeneration, 2005 (Acuity, CARE).

Sub-Investigator: Dexamethasone Posterior Segment Drug Delivery System Applicator in patients with Macular Edema secondary to Retinal Vein Occulsions, 2005 (Allergan RVO)

Principal Investigator: Microcurrent Stimulation for Non-exudative Age-Related Macular Degeneration, 2004 (CibaVision, MCS-500).

Principal Investigator: Visudyne administered in conjunction with Intravitreal Triamcinolone Acetonide in Minimally Classic or Occult Subfoveal Neovascularization in Age Related Macular Degeneration, 2004 (VisTA).

Principal Investigator: Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study, 2004 (Allergan).

Sub-Investigator: Dexamethasone Posterior Segment Drug Delivery System Applicator in patients with Diabetic Macular Edema, 2004 (Allergan DME)

Principal Investigator: Ranibizumab in Predominantly Classic Subfoveal Neovascularization in Age-Related Macular Degeneration, 2004 (Genentech, Anchor).

Sub-Investigator: Effects of Ciclesonide and Beclomethasone on Lens Opacification in Adult Subjects with Moderate to Severe Persistent Asthma, 2004 (PPD Development, Aventis).

Sub-Investigator: Long-Term Safety of Ciclesonide Applied in the Treatment of Perennial Allergic Rhinitis, 2004 (Altana Pharma).

Principal Investigator: Laser Photocoagulation for Diabetic Macular Edema, 2003 (Diabetic Retinopathy Clinical Research Network).

Principal Investigator: Ranibizumab in Minimally Classic or Occult Subfoveal Neovascularization in Age Related Macular Degeneration, 2003 (Genentech, Marina).

Principal Investigator: Visudyne in Occult Choroidal Neovascularization, 2002 (QLT, Inc./VIO).

Principal Investigator: Retisert in Chronic Diabetic Macular Edema, 2002 (Control Delivery Systems).

Principal Investigator: Phase II Study for Dexamethasone Implant for Persistent Macular Edema, 2002 (Oculex).

Principal Investigator: Envision Steroid Implant for Non-Infectious Uveitis, 2002 (Bausch & Lomb).

Principal Investigator: Visudyne (verteporfin) in Age-Related Macular Degeneration Trial, 1999 (Cibavision, Inc.).

Principal Investigator: Prophylactic Treatment for Age-Related Macular Degeneration Trial, 1999

Certified Surgeon: Perfluoron Clinical Trial, 1995-1996 (Escalon, Inc.).

Principal Investigator: Oral Ganciclovir Maintenance Therapy for CMB Retinitis Trial, 1994 (Syntex Pharmaceutical Co.).

Certified Surgeon: Vitrectomy for Macular Hole Study, 1992 - 95.

Certified Surgeon: Vitrectomy for Prevention of Macular Hole Study, 1991 - 1992.

Certified Surgeon: Pneumatic Retinopexy Clinical Trial II, 1990 - 1994.

Certified Surgeon: Silicone Oil Study, 1988 - 1994 (Porex, Co.).

Certified Surgeon, Collaborative Ocular Melanoma Study, 1987 - 1999.

Investigator Krypton-Argon Regression of Neovascularization Study, 1984 - 1991.

Committees:

Chief, Department of Ophthalmology, Seton Hospital, 1999 - 2001.

Chief, Department of Ophthalmology, Brackenridge Hospital, 1994.

Member, Membership Committee, Travis County Medical Society, 1993 - present.

Member, Texas Ophthalmology Association, Ad Hoc Committee for the Diabetes 2000 Project, 1992.

Judge, Miss Austin Beauty Pageant, April 1992.

Member, Disaster and Civil Defense Committee, Travis County Medical Society, 1991 - present.

Member, Laser Committee, Seton Hospital, 1988 - 1990.

Chairman, Texas Diabetes Control Project Advisory Committee, Texas Department of Health, 1987 - 1989

Member, Physician-Nurse Liaison Committee, Seton Hospital, 1989 - present.

Member, Special Committee on AIDS policy, Travis County Medical Society, 1989.

Chairman, Texas Diabetes Control Project Advisory Committee, Austin, Texas, 1987 -1988.

Chief of Ophthalmology, St. DavidŐs Community Hospital, Austin, Texas, 1984 - 1986.

Executive Committee, St. DavidŐs Community Hospital, Austin, Texas, 1984 - 1986.

Research and Education Committee, Scott, Sherwood, and Brindley Foundation, Temple Texas, 1981 - 1983.

Presentations:

Allergan DME and RVO Study Presentations, December 2005.

Experimental Treatments for Macular Degeneration Grand Rounds Presentation, November 11, 2005

Genaera Study Presentation, November 2005.

Retisert Study Presentation, October 2005.

Cand5 Anti VEGF RNAi Evaluation Study Presentation, September 2005.

Dexamethasone Implant Effective Treatment for Persistent Macular Edema, Texas Ophthalmological Association, Austin, Texas, May 2004.

Fluocinolone Acetonide Implantation of Patients with Posterior Uveitis and Diabetic Retinopathy, Austin Ophthalmological Society, Austin, Texas, November 2002.

Fluocinolone Acetonide Implantation of Patients with Posterior Uveitis and Diabetic Retinopathy, Grand Rounds, University of Texas Health Science Center, San Antonio, Texas, August 2002.

New Treatment Techniques in Clinical Research for Chronic Inflammatory Retinal Disease, Grand Rounds, University of Texas Health Science Center, San Antonio, Texas, August 2001.

Posterior Uveitis Cases, Austin, Texas, March 2002.

The Prophylatic Treatment of Age-Related Macular Degeneration Clinical Trial, DMAE Update, Madrid, Spain, April 2001.

New Treatment Techniques for Retinal Diseases, Concepts and Controversies for the Practicing Ophthalmologist, San Antonio, Texas, February 2001.

New Treatments for Macular Degeneration, Texas Ophthalmology and Otorlanygology Annual Meeting, Austin, Texas, March 2000.

Anterior Vitrectomy Techniques for the Comprehensive Ophthalmologist, Grand Rounds at University of Texas Medical Branch at Galveston, September 1998.

Retinitis Update, Austin Ophthalmological Society, Austin, Texas, November 1995.

Management of Progressive Outer Retinal Necrosis in Acquired Immunodeficiency Syndrome, Vitreous Society, 13th Annual Meeting, London, England, August 1995.

Posterior Uveitis, Rotterdam Eye Hospital Grand Rounds, Rotterdam, Netherlands, February 1995.

Neuroretinitis in Patients with AIDS, American Uveitis Society Meeting, San Francisco, California, October 1994.

Ophthalmic Manifestations of Presumed Rifabutin-Related Uveitis, American Uveitis Society Meeting, San Francisco, California, 1994.

Characteristics, Natural History and Risk Factors to Progression in Eyes with Stage 2 Macular Holes, American Academy of Ophthalmology, San Francisco, California, November, 1994.

Baseline Vision Measurements in Patients with Macular Holes, American Academy of Ophthalmology, San Francisco, California, November 1994.

YAG Laser Membranotomy for Macular Hemorrhage From Macroaneurysm, Texas Ophthalmological Association 17th Annual Meeting, Houston, Texas, May 1993.

Posterior Uveitis, Grand Rounds, University of Texas Southwestern Medical Center, Dallas, Texas, February 1992.

Posterior Uveitis, Grand Rounds, Oschner Clinic, New Orleans, Louisiana, January 1992.

Miliary Toxoplasmic Retinitis in a Patient with AIDS. Vitreous Society 9th Annual Meeting, Paris, France, September 1991.

Posterior Uveitis, Grand Rounds, University of Texas Medical Branch, Galveston, Texas, December 1990.

Posterior Uveitis, Grand Rounds, University of Texas Southwestern Medical School, Dallas, Texas, December 1990.

The Management of Macular Hemorrhage from Macroaneurysms. Austin Ophthalmology Society, March 1990.

The Management of Macular Hemorrhage from Macroaneurysms. Vitreous Society 6th Annual Meeting, Orlando, Florida, December 1989.

WhoŐs at Risk for Diabetic Retinopathy. Presented at Symposium on Complications of Diabetes. Texas Medical Association 1989, Annual Session, Forth Worth, Texas, May 1989.

Toxoplasmic Retinitis in AIDS. Vitreous Society 5th Annual Meeting, Scottsdale, Arizona, December 1988.

AIDS: The Acquired Immunodeficiency Syndrome and Its Ophthalmic Manifestations. Texas Medical Association, San Antonio, Texas, May 1988.

Texas Diabetes Control Project. Texas Ophthalmological Association 32nd Annual Meeting, San Antonio, Texas, May 1988.

AIDS: The Acquired Immunodeficiency Syndrome and Its Ophthalmic Manifestations. American Academy of Ophthalmology, Dallas, Texas, November 1987.

Multifocal Choroiditis. American Uveitis Society. Dallas, Texas, November 1987.

Multiple Evanescent White Dot Syndrome. Texas Ophthalmological Assocation 31st Annual Meeting, Houston, Texas, May 1987.

Real Time Fundus Reflectometry Controlled Retinal Photocoagulation. Alamo Alumni Day Meeting, San Antonio, Texas, April 1987.

Real Time Fundus Reflectometry Controlled Retinal Photocoagulation. The Vitreous Society, Palm Springs, California, December 1986.

Retinal Cavernous Hemangiomatosis. Alamo Alumni Day Meeting, San Antonio, Texas, April 1986.

Retinal Cavernous Hemangiomatosis. The Medical College of Wisconsin Eye Institute Resident Alumni Meeting, Milwaukee, Wisconsin, June 1985.

Invasive Melanocytoma. Alamo City Alumni Day, San Antonio, Texas, April 1985.

Invasive Melanocytoma. Vitreo-Retinal Symposium, Lake Tahoe, California, February 1985.

Krypton Photocoagulation of Subretinal Neovascularization. Texas Ophthalmological Association 28th Annual Meeting, Forth Worth, Texas, May 1984.

Krypton Photocoagulation of Subretinal Neovascularization. Hawaiian Ophthalmological Society 5th Annual Meeting, Lahaina, Hawaii, January 1984.

Foveal Burn from Laser Iridotomy. Hawaiian Ophthalmological Society 5th Annual Meeting, Lahaina, Hawaii, January 1984.

Birdshot Retinochoroidopathy. American Uveitis Society Meeting, Chicago, Illinois, October 1983.

Posterior Uveitis. Austin Ophthalmological Society, Austin, Texas, September 1983.

Branch Vein Occlusion. E. Veirs Ophthalmology Conference, Temple, Texas, September 1983.

Complications of Epiretinal Membrane Surgery. Texas Ophthalmological Association 25th Annual Meeting, Dallas, Texas, May 1981.

Epiretinal Membrane Surgery; Hereditary Retinal Dystrophies. Veirs Ophthalmology Conference, Temple, Texas, May 1981.

Epiretinal Membranes. Austin Ophthalmology Society, Austin, Texas, April 1981.

Metastatic Endophthalmitis Complicating Neonatal Streptococcal Septicemia. Interim Meeting of the American Uveitis Society, South Lake Tahoe, Nevada, March 1981.

Posterior Choroidal Melanoma. Department of Ophthalmology, Quarterly Clinical Conference, University of Texas Southwestern Medical School, Dallas, Texas, January 1980.

Vitreous Loss Managed by Anterior Vitrectomy. Alumni Meeting Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, June 1980.

Preretinal Membrane Diseases and Surgical Management. Yale University College of Medicine Department of Ophthalmology and Visual Science Meeting, April 1980.

Anterior Segment Ischemia and FuchŐs Heterochromatic Cyclitis. Interim Meeting of the American Uveitis Society, Phoenix, Arizona, March 1980.

Hereditary Retinal Dystrophies. Pediatric Ophthalmology Clinical Conference, Eye Institute of the Medical College of Wisconsin, Milwaukee, Wisconsin, October
1979.

Management of Vitreous Loss. Illinois Eye and Ear Infirmary, Residents/Alumni Day, 1979.

Long-Term Results of Vitreous Loss Managed by Anterior Vitrectomy. Sixth Biennial Cataract and Intraocular Lens Congress, Houston, Texas, December 3, 1978.

Bilateral Cytomegalovirus Panuveitis Following High Dose Steroid Therapy. Ocular Microbiology and Immunology Group Annual Meeting, Kansas City, Missouri, October 21, 1978.

Alopecia Universals and Cone-Rod Dystrophy. ISCERG Meeting, Ghent, Belgium, 1976.

Lung Cancer: Immunological Effects of Surgery and Radiation Therapy. Senior Scientific Session, University of Chicago School of Medicine Alumni Day, 1975.

Choroidal Vasculature Immunologic Responses Studied by Arterial Injection of Particulate Antigen. ARVO, Sarasota, Florida, 1975.

Video Presentations

Removing Pseudophakic Precipitates with the Tano DDMS, Vitreous Society 18th Annual Meeting, Cancun, Mexico, January 2001.

Wide-Angle Endoillumination. Vitreous Society, St. Thomas, Virgin Islands, 1993.